Large-scale Deep Proteomic Analysis in Alzheimer's Disease Brain Regions Across Race and Ethnicity
Fatemeh Seifar,Edward J Fox,Anantharaman Shantaraman,Yue Liu,Eric B Dammer,Erica Modeste,Duc M Duong,Luming Yin,Adam N Trautwig,Qi Guo,Kaiming Xu,Lingyan Ping,Joseph S Reddy,Mariet Allen,Zachary Quicksall,Laura Heath,Jo Scanlan,Erming Wang,Minghui Wang,Abby Vander Linden,William Poehlman,Xianfeng Chen,Saurabh Baheti,Charlotte Ho,Thuy Nguyen,Geovanna Yepez,Adriana O Mitchell,Stephanie R Oatman,Xue Wang,Minerva M Carrasquillo,Alexi Runnels,Thomas Beach,Geidy E Serrano,Dennis W Dickson,Edward B Lee,Todd E Golde,Stefan Prokop,Lisa L Barnes,Bin Zhang,Varham Haroutunian,Marla Gearing,James J Lah,Philip De Jager,David A Bennett,Anna Greenwood,Nilüfer Ertekin-Taner,Allan I Levey,Aliza Wingo,Thomas Wingo,Nicholas T Seyfried
DOI: https://doi.org/10.1101/2024.04.22.590547
2024-04-26
bioRxiv
Abstract:Introduction: Alzheimer's disease (AD) is the most prevalent neurodegenerative disease, yet our comprehension predominantly relies on studies within the non-Hispanic White (NHW) population. Here we aimed to provide comprehensive insights into the proteomic landscape of AD across diverse racial and ethnic groups. Methods: Dorsolateral prefrontal cortex (DLPFC) and superior temporal gyrus (STG) brain tissues were donated from multiple centers (Mayo Clinic, Emory University, Rush University, Mt. Sinai School of Medicine) and were harmonized through neuropathological evaluation, specifically adhering to the Braak staging and CERAD criteria. Among 1105 DLPFC tissue samples (998 unique individuals), 333 were from African American donors, 223 from Latino Americans, 529 from NHW donors, and the rest were from a mixed or unknown racial background. Among 280 STG tissue samples (244 unique individuals), 86 were African American, 76 Latino American, 116 NHW and the rest were mixed or unknown ethnicity. All tissues were uniformly homogenized and analyzed by tandem mass tag mass spectrometry (TMT-MS). Results: As a Quality control (QC) measure, proteins with more than 50% missing values were removed and iterative principal component analysis was conducted to remove outliers within brain regions. After QC, 9,180 and 9,734 proteins remained in the DLPC and STG proteome, respectively, of which approximately 9,000 proteins were shared between regions. Protein levels of microtubule-associated protein tau (MAPT) and amyloid-precursor protein (APP) demonstrated AD-related elevations in DLPFC tissues with a strong association with CERAD and Braak across racial groups. APOE4 protein levels in brain were highly concordant with APOE genotype of the individuals. Discussion: This comprehensive region resolved large-scale proteomic dataset provides a resource for the understanding of ethnoracial-specific protein differences in AD brain.